Author:

Keywords:

Science & Technology, Life Sciences & Biomedicine, Neurosciences, Neurosciences & Neurology, stroke, upper limb, somatosensation, sensory processing, assessment, robotics, SOMATOSENSORY IMPAIRMENT, STANDARDIZED APPROACH, POSITION SENSE, MOTOR FUNCTION, BARTHEL INDEX, RECOVERY, RELIABILITY, DEFICITS, FREQUENCY, PATIENT, ARM, 1109 Neurosciences, 1701 Psychology, 1702 Cognitive Sciences, 3209 Neurosciences, 5201 Applied and developmental psychology, 5202 Biological psychology

Abstract:

Upper limb sensory processing deficits are common in the chronic phase after stroke and are associated with decreased functional performance. Yet, current clinical assessments show suboptimal psychometric properties. Our aim was to develop and validate a novel robot-based assessment of sensory processing. We assessed 60 healthy participants and 20 participants with chronic stroke using existing clinical and robot-based assessments of sensorimotor function. In addition, sensory processing was evaluated with a new evaluation protocol, using a bimanual planar robot, through passive or active exploration, reproduction and identification of 15 geometrical shapes. The discriminative validity of this novel assessment was evaluated by comparing the performance between healthy participants and participants with stroke, and the convergent validity was evaluated by calculating the correlation coefficients with existing assessments for people with stroke. The results showed that participants with stroke showed a significantly worse sensory processing ability than healthy participants (passive condition: p = 0.028, Hedges' g = 0.58; active condition: p = 0.012, Hedges' g = 0.73), as shown by the less accurate reproduction and identification of shapes. The novel assessment showed moderate to high correlations with the tactile discrimination test: a sensitive clinical assessment of sensory processing (r = 0.52-0.71). We conclude that the novel robot-based sensory processing assessment shows good discriminant and convergent validity for use in participants with chronic stroke.